Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.305 USD | -22.65% | -18.71% | -43.15% |
Feb. 29 | Transcript : Organogenesis Holdings Inc., Q4 2023 Earnings Call, Feb 29, 2024 | |
Feb. 29 | Organogenesis Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 455M | Sales 2025 * | 490M | Capitalization | 393M |
---|---|---|---|---|---|
Net income 2024 * | -2M | Net income 2025 * | 8M | EV / Sales 2024 * | 0.83 x |
Net cash position 2024 * | 15.31M | Net cash position 2025 * | 14.68M | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
-224
x | P/E ratio 2025 * |
31.4
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.31% |
Latest transcript on Organogenesis Holdings Inc.
1 day | -11.41% | ||
1 week | +6.81% | ||
Current month | +4.93% | ||
1 month | +14.18% | ||
3 months | -16.06% | ||
6 months | +29.00% | ||
Current year | -27.14% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 27 M€ | -4.43% | - | |
0.09% | 29 M€ | -3.64% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 2.325 | -21.98% | 756 774 |
24-04-24 | 2.98 | 0.00% | 2,973,406 |
24-04-23 | 2.98 | +0.34% | 631,653 |
24-04-22 | 2.97 | +2.41% | 1,737,377 |
24-04-19 | 2.9 | +1.40% | 421,209 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.14% | 393M | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+45.55% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ORGO Stock